ArticleJournal for immunotherapy of cancer2022

ELK3 modulates the antitumor efficacy of natural killer cells against triple negative breast cancer by regulating mitochondrial dynamics.

Joo Dong Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.